Biotalk

Episode 27: Inside the Biopharma Market: 2025 Outlook & Emerging Trends

7:47

During Episode 27 of Biotalk, Geoff Meyerson, CEO of Locust Walk, steps back to examine the macro forces shaping the biopharma landscape. After holding a bearish outlook since 2021, Geoff explains why he’s finally shifting his stance and what could signal a true turnaround for biotech.

He unpacks the “big three” market headwinds—regulatory hurdles from the IRA, FTC deal scrutiny, and high…